Industry News

Biotech

• Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up 2021/01/15
  Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up ntaylor Fri, 01/15/2021 – 07:49
• Ex-Merck scientist accused of stealing trade secrets on Keytruda, raising threat of 10-year prison term 2021/01/15
  Ex-Merck scientist accused of stealing trade secrets on Keytruda, raising threat of 10-year prison term ntaylor Fri, 01/15/2021 – 05:49
• Meet Binney Street Capital: Dana-Farber Cancer Institute's first venture fund 2021/01/14
  Meet Binney Street Capital: Dana-Farber Cancer Institute's first venture fund badams Thu, 01/14/2021 – 09:27
• Knopp's oral asthma drug hits primary endpoint in phase 2 2021/01/14
  Knopp's oral asthma drug hits primary endpoint in phase 2 ntaylor Thu, 01/14/2021 – 09:06
• NewAmsterdam bags $196M to resurrect Amgen's discarded CETP drug 2021/01/14
  NewAmsterdam bags $196M to resurrect Amgen's discarded CETP drug ntaylor Thu, 01/14/2021 – 08:23

Medical Devices

Error: Feed has an error or is not valid

Pharma

• JPM sound bites, vol. 2: Mushy brains, chewing gum and walking, and that good old San Francisco weather 2021/01/14
  JPM sound bites, vol. 2: Mushy brains, chewing gum and walking, and that good old San Francisco weather chelfand Thu, 01/14/2021 – 11:51
• Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B 2021/01/14
  Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B esagonowsky Thu, 01/14/2021 – 11:28
• Woodcock to step up to interim FDA chief as she and Sharfstein are vetted for permanent job: reports 2021/01/14
  Woodcock to step up to interim FDA chief as she and Sharfstein are vetted for permanent job: reports bbulik Thu, 01/14/2021 – 10:56
• He’s in! Shark Tank’s Mark Cuban launches generics maker promising ‘radically’ low-cost drugs 2021/01/14
  He’s in! Shark Tank’s Mark Cuban launches generics maker promising ‘radically’ low-cost drugs arlene.weintraub Thu, 01/14/2021 – 09:39
• CDMO Catalent tackles Warp Speed juggling act with new $50M Bloomington line, Acorda plant buyout 2021/01/14
  CDMO Catalent tackles Warp Speed juggling act with new $50M Bloomington line, Acorda plant buyout fkansteiner Thu, 01/14/2021 – 08:20

Vaccines

Error: Feed has an error or is not valid